US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
AtaiBeckley Inc. - Common Stock
(NQ:
ATAI
)
7.350
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AtaiBeckley Inc. - Common Stock
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Opening Day: WalkMe Stock Price Falls Following $287M IPO
↗
June 19, 2021
Backed by Insight Venture Partners, WalkMe fell as much as 7% in its trading debut earlier this week after a $287M initial public offering. According to filings, Insight will remain WalkMe's biggest...
Via
Talk Markets
Topics
Initial Public Offering
Peter Thiel-backed Psychedelics Company Rings Nasdaq Bell: Atai Life Sciences Goes Public
↗
June 18, 2021
Atai Life Sciences (NASDAQ:ATAI), a biotech company in the...
Via
Benzinga
New Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End
↗
June 18, 2021
Atai Life Sciences, a backer of psychedelic-drug developers, will start trading Friday, after an upsized offering for the Atai IPO.
Via
Investor's Business Daily
Topics
Initial Public Offering
Is ATAI Stock A Buy After The IPO?
↗
June 16, 2021
ATAI Life Sciences will go public this week. And investors wanting to cash in on one of the hottest medicine and mental health trends need to pay attention to this stock.
Via
Talk Markets
IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings
↗
June 14, 2021
This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going...
Via
Benzinga
Topics
Initial Public Offering
Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation
↗
June 11, 2021
Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offer...
Via
Benzinga
Topics
Initial Public Offering
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
